HEIDELBERG PHARMA AG (HPHA.DE) Stock Earnings & Estimates
Europe - FRA:HPHA - DE000A11QVV0 - Common Stock
3.07 EUR
-0.05 (-1.6%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 18.514M 958.06% | 9.859M -46.75% | 6.849M -30.53% | 9.231M 34.77% | 10.2M 10.50% | 13.26M 30.00% | |
| EBITDA YoY % growth | -17.503M 30.35% | -20.423M -16.69% | -22.98M -12.52% | -33.66M -46.47% | -28.764M 14.55% | -17.595M 38.83% | |
| EBIT YoY % growth | -18.26M 29.59% | -21.302M -16.66% | -23.852M -11.97% | -34.527M -44.76% | -29.937M 13.29% | -19.074M 36.29% | |
| Operating Margin | -98.63% | -216.07% | -348.23% | -374.03% | -293.50% | -143.85% | |
| EPS YoY % growth | N/A 10.49% | N/A -12.50% | N/A 40.28% | -0.63 -44.19% | -0.30 53.23% | -0.20 31.03% |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2021 Q2Q % growth | -0.20 -25.00% | % |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 47.1K -96.05% | % | ||
| Q2 2025 Q2Q % growth | 118.5K -95.75% | % | ||
| Q1 2025 Q2Q % growth | 1.27M 0.27% | % | ||
| Q4 2024 Q2Q % growth | 1.602M -50.33% | % | ||
| Q3 2024 Q2Q % growth | 1.193M -46.82% | % | ||
| Q2 2024 Q2Q % growth | 2.788M 20.34% | % | ||
| Q1 2024 Q2Q % growth | 1.267M -38.94% | % | ||
| Q4 2023 Q2Q % growth | 3.224M 14.37% | % | ||
| Q3 2023 Q2Q % growth | 2.243M -40.34% | % | ||
| Q2 2023 Q2Q % growth | 2.317M -79.35% | % | ||
| Q1 2023 Q2Q % growth | 2.075M 189.90% | % | ||
| Q4 2022 Q2Q % growth | 2.819M 351.59% | % | ||
| Q3 2022 Q2Q % growth | 3.76M 1,123.56% | % | ||
| Q2 2022 Q2Q % growth | 11.219M 2,404.20% | % | ||
| Q1 2022 Q2Q % growth | 715.7K 93.28% | % | ||
| Q4 2021 Q2Q % growth | 624.3K -37.58% | % | ||
| Q3 2021 Q2Q % growth | 307.3K -92.97% | % | ||
| Q2 2021 Q2Q % growth | 448K -72.37% | % | ||
| Q1 2021 Q2Q % growth | 370.3K -75.28% | % | ||
| Q4 2020 Q2Q % growth | 1M -11.47% | % | ||
| Q3 2020 Q2Q % growth | 4.368M 79.92% | % | ||
| Q2 2020 Q2Q % growth | 1.621M -39.53% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 12.06% | 12.06% |
| Revenue | N/A | N/A | 0% | 0% |